Dashboard
Manage Tickers

ARDX ARDELYX, INC.

Nasdaq ardelyx.com


$ 5.58 $ 0.00 (0 %)    

Monday, 03-Nov-2025 19:48:48 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 623.88 $ 0.00 (0 %)
DIA $ 469.78 $ 0.00 (0 %)
SPY $ 676.43 $ 0.00 (0 %)
TLT $ 89.91 $ 0.00 (0 %)
GLD $ 367.22 $ 0.00 (0 %)
$ 5.92
$ 6.07
$ 5.49 x 30
$ 5.62 x 1
-- - --
$ 3.21 - $ 6.78
7,649,919
na
1.44B
$ 0.89
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-30-2025 09-30-2025 10-Q
2 08-04-2025 06-30-2025 10-Q
3 05-01-2025 03-31-2025 10-Q
4 02-20-2025 12-31-2024 10-K
5 10-31-2024 09-30-2024 10-Q
6 08-01-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 02-22-2024 12-31-2023 10-K
9 10-31-2023 09-30-2023 10-Q
10 08-02-2023 06-30-2023 10-Q
11 05-03-2023 03-31-2023 10-Q
12 03-02-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 02-28-2022 12-31-2021 10-K
17 11-12-2021 09-30-2021 10-Q
18 08-13-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 03-08-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 03-06-2020 12-31-2019 10-K
25 11-06-2019 09-30-2019 10-Q
26 08-09-2019 06-30-2019 10-Q
27 05-07-2019 03-31-2019 10-Q
28 03-06-2019 12-31-2018 10-K
29 11-07-2018 09-30-2018 10-Q
30 08-07-2018 06-30-2018 10-Q
31 05-08-2018 03-31-2018 10-Q
32 03-14-2018 12-31-2017 10-K
33 11-07-2017 09-30-2017 10-Q
34 08-09-2017 06-30-2017 10-Q
35 05-05-2017 03-31-2017 10-Q
36 02-17-2017 12-31-2016 10-K
37 11-07-2016 09-30-2016 10-Q
38 08-08-2016 06-30-2016 10-Q
39 05-09-2016 03-31-2016 10-Q
40 03-04-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ardelyx-files-for-mixed-shelf-size-not-disclosed
Ardelyx Files For Mixed Shelf; Size Not Di...
11/03/2025 22:32:06

- SEC Filing

citigroup-maintains-buy-on-ardelyx-raises-price-target-to-11
Citigroup Maintains Buy on Ardelyx, Raises...
11/03/2025 20:37:25

Citigroup analyst Yigal Nochomovitz maintains Ardelyx (NASDAQ:ARDX) with a Buy and raises the price target from $10 to $11.

td-cowen-maintains-buy-on-ardelyx-raises-price-target-to-10
TD Cowen Maintains Buy on Ardelyx, Raises ...
10/31/2025 18:02:42

TD Cowen analyst Joseph Thome maintains Ardelyx (NASDAQ:ARDX) with a Buy and raises the price target from $9 to $10.

cloudflare-posts-upbeat-q3-results-joins-amazon-roku-coinbase-atlassian-and-other-big-stocks-moving-higher-on-friday
Cloudflare Posts Upbeat Q3 Results, Joins ...
10/31/2025 15:37:57

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
10/31/2025 12:10:20

why-amazon-shares-are-trading-higher-by-over-12-here-are-20-stocks-moving-premarket
Why Amazon Shares Are Trading Higher By Ov...
10/31/2025 09:31:59

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/30/2025 21:07:13

ardelyx-q3-sales-110329m-beat-100878m-estimate
Ardelyx Q3 Sales $110.329M Beat $100.878M ...
10/30/2025 20:01:50

Ardelyx (NASDAQ:ARDX) reported quarterly sales of $110.329 million which beat the analyst consensus estimate of $100.878 millio...

earnings-scheduled-for-october-30-2025
Earnings Scheduled For October 30, 2025
10/30/2025 11:12:06

ardelyx-presents-data-supporting-retainagogue-ibsrela-at-acg-annual-scientific-meeting-in-phoenix
Ardelyx Presents Data Supporting Retainago...
10/28/2025 12:02:45

IBSRELA patients reported treatment satisfaction in real-world surveyPost-hoc analysis of T3MPO-1 and T3MPO-2 studies demonstra...

ardelyx-announces-it-will-present-new-data-supporting-its-kidney-disease-drug-xphozah-at-american-society-of-nephrologys-kidney-week-2025-november-59-in-houston-texas
Ardelyx Announces It Will Present New Data...
10/21/2025 12:04:14

Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovati...

ardelyx-appoints-sue-hohenleitner-cfo-effective-nov-4
Ardelyx Appoints Sue Hohenleitner CFO, Eff...
10/13/2025 12:33:25

WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a missi...

4-analysts-assess-ardelyx-what-you-need-to-know
4 Analysts Assess Ardelyx: What You Need T...
08/06/2025 21:01:19

piper-sandler-maintains-neutral-on-ardelyx-raises-price-target-to-9
Piper Sandler Maintains Neutral on Ardelyx...
08/06/2025 16:03:29

Piper Sandler analyst Christopher Raymond maintains Ardelyx (NASDAQ:ARDX) with a Neutral and raises the price target from $8...

wedbush-maintains-outperform-on-ardelyx-raises-price-target-to-14
Wedbush Maintains Outperform on Ardelyx, R...
08/05/2025 15:28:52

Wedbush analyst Laura Chico maintains Ardelyx (NASDAQ:ARDX) with a Outperform and raises the price target from $13 to $14.

raymond-james-maintains-outperform-on-ardelyx-raises-price-target-to-12
Raymond James Maintains Outperform on Arde...
08/05/2025 15:26:00

Raymond James analyst Ryan Deschner maintains Ardelyx (NASDAQ:ARDX) with a Outperform and raises the price target from $11 t...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
08/04/2025 21:07:07

ardelyx-announces-cfoo-justin-renz-will-transition-out-of-company-and-will-stay-on-until-his-successor-is-named
Ardelyx Announces CFOO Justin Renz Will Tr...
08/04/2025 20:15:51

ardelyx-q2-eps-008-beats-012-estimate-sales-97662m-beat-82208m-estimate
Ardelyx Q2 EPS $(0.08) Beats $(0.12) Estim...
08/04/2025 20:05:41

Ardelyx (NASDAQ:ARDX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.12) by 34...

Core News & Articles
Earnings Scheduled For August 4, 2025
08/04/2025 08:32:29

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION